Accuray Inc: Form 10-Q for the period ended Dec 31, 2023
Filed with the SEC on Feb 7, 2024 and accepted by EDGAR at Feb 7, 2024, 16:15 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-10-01 to 2023-12-31 | $107.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2023-07-01 to 2023-12-31 | $211.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-10-01 to 2023-12-31 | $71.3m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2023-07-01 to 2023-12-31 | $135.7m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2023-10-01 to 2023-12-31 | $35.9m | us-gaap:GrossProfit |
| Gross profit | 6 months2023-07-01 to 2023-12-31 | $75.4m | us-gaap:GrossProfit |
| Research and development | 3 months2023-10-01 to 2023-12-31 | $15.3m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2023-07-01 to 2023-12-31 | $29.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2023-10-01 to 2023-12-31 | −$4.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-07-01 to 2023-12-31 | −$1.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-10-01 to 2023-12-31 | $2.9m | us-gaap:InterestExpense |
| Interest expense | 6 months2023-07-01 to 2023-12-31 | $5.8m | us-gaap:InterestExpense |
| Income tax | 3 months2023-10-01 to 2023-12-31 | $878.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-07-01 to 2023-12-31 | $2.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-10-01 to 2023-12-31 | −$9.6m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-07-01 to 2023-12-31 | −$12.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-10-01 to 2023-12-31 | −$0.10 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-07-01 to 2023-12-31 | −$0.13 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-10-01 to 2023-12-31 | −$0.10 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-07-01 to 2023-12-31 | −$0.13 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-10-01 to 2023-12-31 | 97,776,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-07-01 to 2023-12-31 | 97,165,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-07-01 to 2023-12-31 | −$13.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-07-01 to 2023-12-31 | $2.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2023-12-31 | $72.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-12-31 | $331.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-12-31 | $476.4m | us-gaap:Assets |
| Current liabilities | At period end2023-12-31 | $209.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-12-31 | $428.7m | us-gaap:Liabilities |
| Long-term debt | At period end2023-12-31 | $168.0m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-12-31 | $6.7m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2023-12-31 | $6.7m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2023-12-31 | $47.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-24-012210. Last ingested by Listed: Oct 30, 2026, 16:06 ET. Listed shows no prices and gives no investment advice.